Price (delayed)
$7.93
Market cap
$300.97M
P/E Ratio
9.79
Dividend/share
N/A
EPS
$0.81
Enterprise value
$286.18M
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody,
There are no recent dividends present for TRDA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.